MicrobiologybioRxivPreprint
A single-dose recombinant rVSVΔG-CCHFV-GPC vaccine protects nonhuman primates against heterologous Crimean-Congo hemorrhagic fever virus challenge
Robert W. Cross, Kevin Melody, Rachel L O'Toole…·Thomas W. Geisbert
This study shows a single dose of a recombinant rVSV vaccine protects nonhuman primates from CCHFV infection, with immune responses similar to human survivors.
DOI 10.64898/2026.10.21.760752